Skip to main content

#Influenza and Other Respiratory Viruses Research #References (by AMEDEO, March 15 '25)

Image
By G.M.

 


    Biochemistry (Mosc)

  1. FILIPPOVA TA, Masamrekh RA, Farafonova TE, Khudoklinova YY, et al
    Determination of SARS-CoV-2 Main Protease (M(pro)) Activity Based on Electrooxidation of Tyrosine Residue of a Model Peptide.
    Biochemistry (Mosc). 2025;90:120-131.
    PubMed         Abstract available


    BMC Pediatr

  2. JAYARATNE K, Illangasinghe P, Wanniarachchi S, Hettiarachchi D, et al
    Epidemic profile of COVID-19 child deaths in Sri Lanka: a retrospective nationwide analysis.
    BMC Pediatr. 2025;25:174.
    PubMed         Abstract available


    Cell

  3. XING L, Liu Z, Wang X, Liu Q, et al
    Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target.
    Cell. 2025;188:1297-1314.
    PubMed         Abstract available


    J Epidemiol Community Health

  4. COSTE M, Prah JJ
    Applying the health capability profile: an analytical study of leading causes of death in the USA and of pressing public health issues.
    J Epidemiol Community Health. 2025;79:302-310.
    PubMed         Abstract available

  5. AGARWAL G, Keshavarz H, Angeles R, Pirrie M, et al
    SARS-CoV-2 testing, test positivity and vaccination in social housing residents compared with the general population: a retrospective population-based cohort study.
    J Epidemiol Community Health. 2025;79:233-238.
    PubMed         Abstract available

  6. JIN H, Lee WJ, Maupin D, Lee JO, et al
    Within-person relationship between employment insecurity and mental health: a longitudinal analysis of the Understanding America Study.
    J Epidemiol Community Health. 2025;79:265-271.
    PubMed         Abstract available


    J Immunol

  7. GROVENSTEIN P, Bhatnagar N, Kim KH, Pal SS, et al
    Influenza 5xM2e mRNA lipid nanoparticle vaccine confers broad immunity and significantly enhances the efficacy of inactivated split vaccination when coadministered.
    J Immunol. 2025;214:104-114.
    PubMed         Abstract available

  8. QIAO P, Yue C, Peng W, Liu K, et al
    Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2.
    J Immunol. 2025;214:115-129.
    PubMed         Abstract available

  9. WANG M, Liu C, Fan Q, Sun Y, et al
    Rapid clonal expansion and somatic hypermutation contribute to the fate of SARS-CoV-2 broadly neutralizing antibodies.
    J Immunol. 2025;214:278-289.
    PubMed         Abstract available


    J Infect Dis

  10. VILLALOBOS RODRIGUEZ AP, Wellington Perkins I, Moosavi S, de la Garza A, et al
    Pandemic Preparedness: Analyzing National Plans for Respiratory Pathogen Pandemics in the Americas Region.
    J Infect Dis. 2025;231.
    PubMed         Abstract available

  11. REDONDO-BRAVO L, Zureick K, Voto C, Molina Avendano X, et al
    A Comparative Analysis of Universal and Sentinel Surveillance Data for Coronavirus Disease 2019: Insights From Argentina, Chile, and Mexico (2020-2022).
    J Infect Dis. 2025;231.
    PubMed         Abstract available

  12. RODRIGUEZ A, Couto P, Acevedo A, Herrera BA, et al
    Strengthening the Surveillance and Response to Public Health Events With a One Health Approach: A Perspective From 12 Countries in Latin America and the Caribbean.
    J Infect Dis. 2025;231.
    PubMed         Abstract available


    JAMA

  13. MAIA IS, Kawano-Dourado L, Tramujas L, de Oliveira NE, et al
    High-Flow Nasal Oxygen vs Noninvasive Ventilation in Patients With Acute Respiratory Failure: The RENOVATE Randomized Clinical Trial.
    JAMA. 2024 Dec 10. doi: 10.1001/jama.2024.26244.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  14. ZHU S, Harriman K, Liu C, Kraushaar V, et al
    Human Cases of Highly Pathogenic Avian Influenza A(H5N1) - California, September-December 2024.
    MMWR Morb Mortal Wkly Rep. 2025;74:127-133.
    PubMed         Abstract available


    PLoS Comput Biol

  15. AMARAL AVR, Wolffram D, Moraga P, Bracher J, et al
    Post-processing and weighted combination of infectious disease nowcasts.
    PLoS Comput Biol. 2025;21:e1012836.
    PubMed         Abstract available


    PLoS Med

  16. AHMADI-ABHARI S, Bandosz P, Shipley MJ, Lindbohm JV, et al
    Direct and indirect impacts of the COVID-19 pandemic on life expectancy and person-years of life lost with and without disability: A systematic analysis for 18 European countries, 2020-2022.
    PLoS Med. 2025;22:e1004541.
    PubMed         Abstract available


    PLoS One

  17. ADAMU H, Lawal S, Bawa IA, Sani AM, et al
    Prevalence and pattern of adverse events following COVID-19 vaccination among adult population in Sokoto metropolis, northwest, Nigeria.
    PLoS One. 2025;20:e0277585.
    PubMed         Abstract available

  18. GONCALVES NV, Leal AL, Guimaraes HMMES, Bernardes AC, et al
    The territorialization of Severe Acute Respiratory Syndrome and its socioeconomic, demographic and public health policy risk factors in Belem, state of Para, Eastern Amazon, Brazil: a cross-sectional and ecological study.
    PLoS One. 2025;20:e0318607.
    PubMed         Abstract available

  19. DEGUCHI Y, Iwasaki S, Uesaka Y, Okawa Y, et al
    Remote work and long-term sickness absence due to mental disorder trends among Japanese workers pre/post COVID-19.
    PLoS One. 2025;20:e0319825.
    PubMed         Abstract available

  20. HTET H, Wichaidit W, Chuaychai A, Sottiyotin T, et al
    Perspectives of stakeholders on barriers to COVID-19 protective behaviors adherence and vaccination among Myanmar migrant workers in southern Thailand: A qualitative study.
    PLoS One. 2025;20:e0317714.
    PubMed         Abstract available

  21. MOHRI P, Koyluoglu YO, Seker ME, Sancak SN, et al
    Medical students' perception of paid E-learning.
    PLoS One. 2025;20:e0317340.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  22. WANG Q, Xu S, Shen W, Wei Y, et al
    N6-methyladnosine of vRNA facilitates influenza A virus replication by promoting the interaction of vRNA with polymerase proteins.
    Proc Natl Acad Sci U S A. 2025;122:e2411554122.
    PubMed         Abstract available


    Vaccine

  23. KRAMMER F
    Next-generation seasonal influenza virus vaccines need a neuraminidase component.
    Vaccine. 2025;54:126994.
    PubMed        

  24. OTIENO NA, Kalani R, Ayugi J, Nyawanda BO, et al
    Seasonal influenza vaccination in Kenya: What determines healthcare Workers' willingness to accept and recommend vaccination?
    Vaccine. 2025;54:126963.
    PubMed         Abstract available


    Virology

  25. OSPINA-JIMENEZ AF, Gomez AP, Rincon-Monroy MA, Perez DR, et al
    A novel reassorted swine H3N2 influenza virus demonstrates an undetected human-to-swine spillover in Latin America and highlights zoonotic risks.
    Virology. 2025;606:110483.
    PubMed         Abstract available

  26. PAWAR SD, Keng SS, Tare DS, Balakrishnan A, et al
    Evidence of novel reassortment in clade 2.3.4.4b avian influenza H5N1 viruses, India, 2024.
    Virology. 2025;606:110482.
    PubMed         Abstract available
Labels:

Comments

Post a Comment

Popular posts from this blog

#Neuroinvasive #Oropouche virus in a patient with #HIV from extra-Amazonian #Brazil

By G.M.
{Excerpt} A novel reassortant Oropouche virus (OROV) lineage (with medium [M], large [L], and small [S] RNA segments : M1L2S2) has driven Brazil's largest and most geographically widespread OROV epidemic , expanding beyond the endemic Amazon basin to establish local transmission across multiple Brazilian states and other previously unaffected Latin American countries . The rapid spread of this lineage underscores its evolutionary potential and reinforces its significance as a public health threat .1 Similar to chikungunya and Zika viruses, expanding arboviruses can exhibit unexpected clinical and epidemiological shifts , including vertical transmissions , neuroinvasive effects, and potentially fatal outcomes.2–4 Although OROV typically causes self-limited febrile illness, accumulating clinical and experimental evidence suggests neurotropic potential .5 This Correspondence describes the first confirmed case of neuroinvasive OROV infection caused by the emergent M1L2S2 lineage in ext...
Post a Comment
Read more »

No evidence of immune #exhaustion after repeated #SARS-CoV-2 #vaccination in vulnerable and healthy populations

By G.M.
Abstract Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion , which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada . Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was...
Post a Comment
Read more »

Chimeric #hemagglutinin and #M2 #mRNA #vaccine for broad #influenza subtype protection

By G.M.
Abstract Since multiple and unpredicted influenza viruses cause seasonal epidemics and even high-risk pandemics , developing a universal influenza vaccine is essential to provide broad protection against various influenza subtypes. Combined with the mRNA lipid nanoparticle-encapsulated (mRNA-LNP) vaccine platform and chimeric immunogen strategy , we developed a novel cocktail mRNA vaccine encoding chimeric HAs (cH5/1-BV, cH7/3) and intact M2 (termed Fluaxe), which confers broad protection against major circulating IAVs and IBVs , as well as highly pathogenic avian influenza . Two-dose intramuscular immunization of Fluaxe in mice elicited cross-reactive neutralizing antibodies , T cell responses, and long-lived immunity, resulting in robust protection against multiple lethal influenza virus infections and severe acute lung injuries . In particular, intramuscular administration stimulated systemic immunity together with a prominent lung tropism of memory cells . Moreover, Fluaxe immuniza...
Post a Comment
Read more »